Ionetix (IONTX US)

Ionetix Corporation develops superconducting cyclotron technology for medical and industrial applications. The company generates revenue from diagnostic radioisotopes, such as PET imaging isotopes F-18, Ga-68, and N-13, and therapeutic alpha-emitting isotopes like Ac-225 and At-211, while also exploring other applications for its particle accelerator technology.